Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus.

Abstract:

OBJECTIVE:To investigate the clinical characteristics, imaging changes and early diagnostic methods of neuropsychiatric systemic lupus erythematosus (NPSLE). METHODS:Thirty-five SLE patients, of which 16 had overt neuropsychiatric symptoms, underwent examination for multiple autoantibodies, including anti-double-stranded DNA (anti-dsDNA) antibody, anti-nucleosome antibody, anti-cardiac-phospholipid antibody (aCL)-IgG, aCL-IgM, anti-β2-glycoprotein I antibody and anti-ribosomal P antibody, and the SLEDAI score of every patient was recorded. All patients further received neuropsychological tests, including the Mini-Mental State Examination, the Self-Rating Anxiety Scale and the Self-Rating Depression Scale. Imaging examination using 3D arterial spin labeling was performed on 3.0 T MRI scanners. After processing the 3D arterial spin labeling image, the cerebral blood flow map was obtained and the cerebral blood flow value was calculated. RESULTS:The values of anti-dsDNA, anti-nucleosome antibody, aCL-IgG and anti-β2-glycoprotein I antibodies were significantly higher in the NPSLE group than those in the SLE group. The SLEDAI scores of the NPSLE group were significantly higher than those of the SLE group. There were no significant differences between the NPSLE group and the SLE group in the directional ability, memory, attention, numeracy, recall ability or language ability scores on the Mini-Mental State Examination scale. Furthermore, there were no symptoms of anxiety or depression in any of the patients, according to the Self-Rating Anxiety Scale and Self-Rating Depression Scale. In the 35 patients with SLE, decreases in blood perfusion were seen in some areas, and were unilateral and asymmetrically distributed. There was obvious asymmetry between sides in areas including the frontal lobe, temporal lobe, parietal lobe and occipital lobe. The incidence of perfusion decreases in frontal lobe in the NPSLE group was significantly higher than in the SLE group. CONCLUSION:Neurological lesions in SLE patients can be detected by arterial spin labeling. Cerebral blood flow abnormalities may be helpful for the early diagnosis of neurological lesions in NPSLE.

journal_name

Lupus

journal_title

Lupus

authors

Jia J,Xie J,Li H,Wei H,Li X,Hu J,Meng D,Zhang Y,Zhang X

doi

10.1177/0961203319861677

subject

Has Abstract

pub_date

2019-08-01 00:00:00

pages

1128-1133

issue

9

eissn

0961-2033

issn

1477-0962

journal_volume

28

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients.

    abstract::The aim of this study was to determine the frequency of anti-prolactin autoantibodies and the relationship among anti-prolactin autoantibodies, serum prolactin (PRL) levels and lupus activity in paediatric patients with systemic lupus erythematosus (SLE) using a transversal study. One-hundred and three consecutive pae...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120330101001107

    authors: Blanco-Favela F,Quintal MaG,Chavez-Rueda AK,Leaños-Miranda A,Berron-Peres R,Baca-Ruiz V,Lavalle-Montalvo C

    更新日期:2001-01-01 00:00:00

  • Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand.

    abstract:Background:Strongyloidiasis can be fatal in systemic lupus erythematosus (SLE) patients, but few epidemiological studies have investigated the burden of this tropical disease among the SLE population. This study aimed to assess the prevalence and associated factors of strongyloidiasis among SLE patients in Southern Tha...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320911091

    authors: Juthong S,Geater AF,Dekumyoy P,Hortiwakul T,Siripaitoon B,Aiewruengsurat D,Thongbun N

    更新日期:2020-05-01 00:00:00

  • Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus.

    abstract::Children born to women with systemic lupus erythematosus seem to have a potentially increased risk of neurodevelopmental disorders compared to children born to healthy women. Recent experimental data suggest in utero exposure to maternal antibodies and cytokines as important risk factors for neurodevelopmental disorde...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314541691

    authors: Vinet É,Pineau CA,Clarke AE,Fombonne É,Platt RW,Bernatsky S

    更新日期:2014-10-01 00:00:00

  • Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.

    abstract::Although many types of neurological disorders and events have been described in association with antiphospholipid antibodies (aPL) and the antiphospholipid syndrome (APS), only ischaemic stroke is reasonably well established and accepted as a diagnostic criterion for the syndrome. We propose to evaluate, classify and ...

    journal_title:Lupus

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1191/0961203303lu392oa

    authors: Chapman J,Rand JH,Brey RL,Levine SR,Blatt I,Khamashta MA,Shoenfeld Y

    更新日期:2003-01-01 00:00:00

  • Allergic disorders in systemic lupus erythematosus.

    abstract::Allergic disorders commonly occur in patients with systemic lupus erythematosus (SLE) and allergies to some drugs may occasionally be related to disease flares. We evaluated the prevalence of several types of allergy in 132 patients with SLE and their families and compared the SLE patients with a control group of 66 p...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200311

    authors: Sequeira JF,Cesic D,Keser G,Bukelica M,Karanagnostis S,Khamashta MA,Hughes GR

    更新日期:1993-06-01 00:00:00

  • Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.

    abstract::Up to 80% of patients with systemic lupus erythematosus (SLE) are treated with nonsteroidal anti-inflammatory drugs (NSAID) for musculoskeletal symptoms, serositis and headache. This survey reviews the literature on non-selective and selective inhibitors of cyclooxygenases, with an emphasis on the efficacy and safety ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120300678828794

    authors: Ostensen M,Villiger PM

    更新日期:2000-01-01 00:00:00

  • Association of ficolin-2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study.

    abstract:BACKGROUND:Pediatric-onset SLE (pSLE) is a multisystem autoimmune disease. Recently, the ficolin-2 (FCN2) gene has emerged as a potential candidate gene for susceptibility to SLE. OBJECTIVES:The objective of this study was to evaluate the association of the FCN2 gene polymorphisms at positions -986 (G/A), -602 (G/A), ...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319856089

    authors: Elkoumi MA,Emam AA,Allah MAN,Sherif AH,Abdelaal NM,Mosabah A,Zakaria MT,Soliman MM,Salah A,Sedky YM,Mashali MH,Elashkar SSA,Hafez SFM,Hashem MIA,Elshreif AM,Youssef M,Fahmy DS,Sallam MM,Nawara AM,Elgohary EA,Ahmed

    更新日期:2019-07-01 00:00:00

  • Interstitial inflammation and long-term renal outcomes in lupus nephritis.

    abstract:INTRODUCTION:The International Society of Nephrology/Renal Pathology Society (ISN/RPS) pathological classification criteria of lupus nephritis are limited to glomerular injury. Although the tubulointerstitium is commonly involved, the importance of such involvement is not well defined. The major objective of this study...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313507986

    authors: Alsuwaida AO

    更新日期:2013-12-01 00:00:00

  • Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.

    abstract::Anti-phospholipid antibodies are common in patients in the Hopkins' Lupus Cohort: 47% have anti-cardiolipin, 32.5% anti-beta(2)-glycoprotein I and 26% lupus anticoagulant (by dRVVT confirmatory testing). Systemic lupus erythematosus patients with the lupus anticoagulant at baseline have a 50% chance of a deep venous t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309360541

    authors: Petri M

    更新日期:2010-04-01 00:00:00

  • Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature.

    abstract::Systemic lupus erythematosus (SLE) often coexists with other diseases. Diabetes mellitus (DM) is an example and patients with overlap SLE-DM can present with clinical features common to both disorders. In this review, we describe the patients with overlap SLE-DM, focussing on the clinical features common to both disea...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308091539

    authors: Cortes S,Chambers S,Jerónimo A,Isenberg D

    更新日期:2008-11-01 00:00:00

  • Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.

    abstract::Systemic lupus erythematosus (SLE) is characterized by multiple autoantibodies and complement activation. Recent studies have suggested that anti-nuclear antibody (ANA) positivity may disappear over time in some SLE patients. Anti-double-stranded DNA (dsDNA) antibody titers and complement levels may vary with time and...

    journal_title:Lupus

    pub_type: 历史文章,杂志文章

    doi:10.1177/0961203310385738

    authors: Ippolito A,Wallace DJ,Gladman D,Fortin PR,Urowitz M,Werth V,Costner M,Gordon C,Alarcón GS,Ramsey-Goldman R,Maddison P,Clarke A,Bernatsky S,Manzi S,Bae SC,Merrill JT,Ginzler E,Hanly JG,Nived O,Sturfelt G,Sanchez-Gu

    更新日期:2011-03-01 00:00:00

  • Belimumab in refractory organizing pneumonia associated with systemic lupus erythematosus: a case report.

    abstract::Organizing pneumonia is an inflammatory lung entity that presents with a huge variety of clinical, radiological and pathological patterns. Organizing pneumonia can be idiopathic or secondary to other diseases. Corticosteroid therapy is usually the first-line treatment showing clinical improvement in most cases. This r...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319835320

    authors: Giménez AR,Pastrana DB,Huaranga MAR,Izquierdo JR,Cabrera B,García AN,Rodríguez CCR

    更新日期:2019-04-01 00:00:00

  • Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.

    abstract::Data related to the disease course of patients with systemic lupus erythematosus (SLE) with special attention to the persistence of disease activity in the long term are scarce. At this moment reliable figures are only known about the survival rate as a measure of outcome. The aim of this multicenter study was to desc...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1191/096120301666282314

    authors: Swaak AJ,van den Brink HG,Smeenk RJ,Manger K,Kalden JR,Tosi S,Domljan Z,Rozman B,Logar D,Pokorny G,Kovacs L,Kovacs A,Vlachoyiannopoulos PG,Moutsopoulos HM,Chwalinska-Sadowska H,Kiss E,Cikes N,Anic B,Schneider M,Fisc

    更新日期:2001-01-01 00:00:00

  • PRISM (Pictorial Representation of Illness and Self Measure)- a novel visual method to assess the global burden of illness in patients with systemic lupus erythematosus.

    abstract:OBJECTIVE:For patients with chronic illnesses the global burden of illness is a crucial health measure hitherto neglected in research studies and clinical practice. We tested the application and validity of PRISM (Pictorial Representation of Illness and Self-Measure), a novel visual method for assessing the burden of i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120300678828479

    authors: Büchi S,Villiger P,Kauer Y,Klaghofer R,Sensky T,Stoll T

    更新日期:2000-01-01 00:00:00

  • Why not work on T and NK cells in the Kunkel laboratory?

    abstract::Coming from Hans Wigzell's laboratory in Uppsala, Sweden, I joined the Kunkel laboratory in 1981 to spend a post-doctoral fellowship period financed by the German Research Organization. While I initially worked with Nick Chiorazzi in an attempt to generate monoclonal antibody-secreting human B-cell hybridomas, I later...

    journal_title:Lupus

    pub_type: 传,历史文章,杂志文章

    doi:10.1191/0961203303lu355xx

    authors: Kabelitz D

    更新日期:2003-01-01 00:00:00

  • The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review.

    abstract::Pericardial effusions causing pericardial tamponade are rare in patients with systemic lupus erythematosus (SLE). The goal of this study is to describe in detail the clinical and laboratory characteristics of a group of patients with pericardial effusions and pericardial tamponade secondary to SLE. We retrospectively ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308100659

    authors: Rosenbaum E,Krebs E,Cohen M,Tiliakos A,Derk CT

    更新日期:2009-06-01 00:00:00

  • Headaches in patients with systemic lupus erythematosus: a comparative study.

    abstract::The incidence and nature of headaches in 85 systemic lupus erythematosus (SLE) patients attending an outpatient clinic were studied and compared to those experienced by 61 nurses. The two groups were similar in age, sex and ethnicity. Test-retest assessment of reliability gave both groups 95% confidence limits of 0.09...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1050oa

    authors: Whitelaw DA,Hugo F,Spangenberg JJ,Rickman R

    更新日期:2004-01-01 00:00:00

  • Association between shortened telomere length and systemic lupus erythematosus: a meta-analysis.

    abstract::Objective We aimed to evaluate the relationship between telomere length and systemic lupus erythematosus (SLE). Methods PUBMED and EMBASE databases were searched; meta-analyses were performed comparing telomere length in SLE patients and healthy controls, and on SLE patients in subgroups based on ethnicity, sample typ...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203316662721

    authors: Lee YH,Jung JH,Seo YH,Kim JH,Choi SJ,Ji JD,Song GG

    更新日期:2017-03-01 00:00:00

  • Severe valvular heart disease in a patient with primary antiphospholipid syndrome.

    abstract::Valvular replacement was performed in a patient with primary antiphospholipid syndrome and severe mitral insufficiency. The valvular tissue presented thrombotic phenomena and fibrosis with minimum inflammatory component. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:

    authors: Alvarez-Blanco A,Egurbide-Arberas MV,Aguirre-Errasti C

    更新日期:1994-10-01 00:00:00

  • Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1.

    abstract::Renal involvement is one of the main complications of systemic lupus erythematosus, causing a significant impact on patients' morbidity and mortality. Renal biopsy is still the gold standard of diagnosis, but it has many limitations. In this sense, several recent studies aim to identify biomarkers that not only predic...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203319826695

    authors: Gasparin AA,Pamplona Bueno de Andrade N,Hax V,Tres GL,Veronese FV,Monticielo OA

    更新日期:2019-03-01 00:00:00

  • Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?

    abstract::Neonatal antiphospholipid syndrome (neonatal APS) seems to be exceedingly rare, as the antiphospholipid antibodies (aPL) related thrombosis in the neonatal period. The pathogenesis of perinatal aPL related thrombosis may be explained both by the transplacental passage of the maternal antibodies and by the production o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314560207

    authors: De Carolis MP,Salvi S,Botta A,Cocca C,Garufi C,Lanzone A,De Carolis S

    更新日期:2015-03-01 00:00:00

  • Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England.

    abstract:OBJECTIVES:Systemic lupus erythematosus (SLE) is a chronic, multisystemic, immune-mediated disorder associated with a substantial hospitalization risk. As a comparatively rare disease, there is a sparsity of research examining the burden of hospital admission in the contemporary era. We aim to describe national trends ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319853357

    authors: Hannah J,Galloway J,Kaul A

    更新日期:2019-06-01 00:00:00

  • Chronic intestinal pseudo-obstruction: a rare first manifestation of systemic lupus erythematosus.

    abstract::Chronic intestinal pseudo-obstruction (CIPO) is a rare clinical syndrome of ineffective intestinal motility characterised by clinical and radiological evidence of intestinal obstruction with no identifiable mechanical lesion. CIPO can either be idiopathic or secondary to a systemic disease, like systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313492873

    authors: Khairullah S,Jasmin R,Yahya F,Cheah TE,Ng CT,Sockalingam S

    更新日期:2013-08-01 00:00:00

  • Genetic selection pressure in TLR9 gene may enforce risk for SLE in Indian Tamils.

    abstract::Objectives Lupus is a classical systemic autoimmune disease with genetics as one of the well known causative factors for the disease pathogenesis. Toll-like receptors are the major pattern recognition receptors associated with innate immunity and also act as an interface with the adaptive immunity. Genetic polymorphis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316659151

    authors: Yusuf JH,Kaliyaperumal D,Jayaraman M,Ramanathan G,Devaraju P

    更新日期:2017-03-01 00:00:00

  • Kidney transplantation in lupus patients: a case-control study from a single centre.

    abstract::This study was conducted to determine kidney transplantation (KTx) outcomes for Greek patients with renal failure caused by lupus nephritis (LN) compared with matched controls, kidney recipients with other causes of end-stage renal disease (ESRD). Twenty-six patients with systemic lupus erythematosus (SLE) subjected t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089430

    authors: Lionaki S,Kapitsinou PP,Iniotaki A,Kostakis A,Moutsopoulos HM,Boletis JN

    更新日期:2008-07-01 00:00:00

  • Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic.

    abstract:OBJECTIVE:Systemic lupus erythematosus (SLE), an autoimmune condition with diverse clinical manifestations, is reported to have different expression in populations of different ancestry. Most previous studies compared patients of different ethnic groups from geographically distinct cohorts. In our study, we aimed to ch...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313500547

    authors: Golder V,Connelly K,Staples M,Morand E,Hoi A

    更新日期:2013-11-01 00:00:00

  • Wegener's granulomatosis: disease course, assessment of activity and extent and treatment.

    abstract::Wegener's granulomatosis (WG) belongs to the group of necrotizing primary systemic vasculitides of unknown etiology, that are associated with anti-neutrophil cytoplasmic antibodies. The pathological hallmark of WG is the coexistence of vasculitis and granuloma. Due to more sensitive diagnostic instruments, especially ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920118

    authors: de Groot K,Gross WL

    更新日期:1998-01-01 00:00:00

  • Effectiveness of pharmaceutical care for drug treatment adherence in women with lupus nephritis in Rio de Janeiro, Brazil: a randomized controlled trial.

    abstract:OBJECTIVE:Studies have been conducted to determine the causal factors and clinical consequences of non-adherence to treatment in systemic lupus erythematosus (SLE). However, no interventions have been performed to increase drug adherence. Our objective was to assess the effectiveness of pharmaceutical care (PC) for dru...

    journal_title:Lupus

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/0961203319877237

    authors: Oliveira-Santos M,Verani JFS,Camacho LAB,de Andrade CAF,Klumb EM

    更新日期:2019-10-01 00:00:00

  • Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.

    abstract:BACKGROUND:Current non-invasive methods of assessing disease activity in systemic lupus erythematosus (SLE) are of limited sensitivity and specificity. Testing includes acute phase markers, autoantibodies and complement levels. Although measurements of dsDNA antibodies and complement C3/C4 levels are routine, they rema...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319845487

    authors: Adhya Z,El Anbari M,Anwar S,Mortimer A,Marr N,Karim MY

    更新日期:2019-05-01 00:00:00

  • Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand.

    abstract::Background The prevalence and variation by ethnicity of cutaneous lupus in New Zealand is not known. Therefore, a cross-sectional study to determine the prevalence and variation by ethnicity of cutaneous lupus in the ethnically diverse community of South Auckland, New Zealand, was undertaken. Methods Multiple sources ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316651745

    authors: Jarrett P,Thornley S,Scragg R

    更新日期:2016-11-01 00:00:00